Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Dusseldorf - Delayed Quote EUR

Ocular Therapeutix Inc (0OT.DU)

6.82
-0.06
(-0.84%)
At close: April 25 at 7:30:17 PM GMT+2
Loading Chart for 0OT.DU
  • Previous Close 6.88
  • Open 0.00
  • Bid --
  • Ask --
  • Day's Range 0.00 - 0.00
  • 52 Week Range 0.00 - 10.65
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 0OT.DU

View More

Performance Overview: 0OT.DU

Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

0OT.DU
13.99%
S&P 500 (^GSPC)
6.06%

1-Year Return

0OT.DU
73.64%
S&P 500 (^GSPC)
9.44%

3-Year Return

0OT.DU
89.03%
S&P 500 (^GSPC)
28.61%

5-Year Return

0OT.DU
18.68%
S&P 500 (^GSPC)
94.77%

Compare To: 0OT.DU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0OT.DU

View More

Valuation Measures

Annual
As of 4/25/2025
  • Market Cap

    1.08B

  • Enterprise Value

    803.22M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    19.20

  • Price/Book (mrq)

    3.90

  • Enterprise Value/Revenue

    14.28

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 0OT.DU

View More

Company Insights: 0OT.DU

Research Reports: 0OT.DU

View More